Clinical Trials Sponsored by Mesoestetic Pharma Group S.L.

Total 21 results

Mesoestetic Pharma Group S.L.

Completed

Assessment of the Safety and Efficacy of the Dermal Filler "mARG-01-17" in Facial Rejuvenation Therapy

Facial Rejuvenation

Bulgaria
Mesoestetic Pharma Group S.L.

Completed

Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina.

Urinary Incontinence | Vaginal Atrophy | Vulvovaginal Signs and Symptoms | Dyspareunia

Bulgaria
Mesoestetic Pharma Group S.L.

Completed

Clinical Investigation to Assess Safety and Performance of Dermal Filler of Hyaluronic Acid

Wrinkle | Skin Folds

Spain
Mesoestetic Pharma Group S.L.

Completed

Evaluation of the Efficacy and Safety of the Dermal Filler for Augmentation of Labia Majora.

Labia Majora Atrophy and Hypotrophy

Bulgaria
Mesoestetic Pharma Group S.L.

Completed

Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma

Facial Melasma

Spain
Mesoestetic Pharma Group S.L.
Opera CRO, a TIGERMED Group Company

Completed

Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation

Facial Rejuvenation

Romania
Aileens Pharma SRL
Advice Pharma Group srl

Recruiting

Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic Dermatitis

Atopic Dermatitis

Italy
Advice Pharma Group srl

Recruiting

KidneYou - Innovative Digital Therapy

Diabetes | Chronic Kidney Diseases | Tuberous Sclerosis | Albuminuria | Treatment Adherence | Arterial Hypertension | Treatment Adherence and Compliance | Nephronophthisis | Polycystic Kidney | Chronic Glomerulonephritis | Cystic Kidney Diseases | Cortical Cystic Disease | Cystic Diseases

Italy
Advice Pharma Group srl

Active, not recruiting

DEMETRA - ADVICE-002-2022

Obesity | Nutrition Disorders | Body Weight | Weight Loss | Dietary Habits | Overweight and Obesity | Health Behavior | Diet, Healthy | Diet Habit | Life Style | Nutrition, Healthy | Behavioral Disorder

Italy
Advice Pharma Group srl

Completed

MargheRITA (Remote Intelligence for Therapeutic Adherence) (MargheRITA)

Acute Myeloid Leukemia | Multiple Myeloma | Hodgkin Lymphoma | Amyloidosis | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Treatment Adherence | Myelodysplasia | Lymphocytic Lymphoma | Treatment Adherence and Compliance | T Cell Non-Hodgkin Lymphoma | B-cell Non Hodgkin Lymphoma | Solitary Plasmacytoma and other conditions

Italy
Tensive SRL
Advice Pharma Group srl

Active, not recruiting

REGENERA Implant in Localized Non-malignant Breast Lesions Treated by Excision or Lumpectomy - Long-term Follow-up

Breast Diseases

Italy
ITEL Telecomunicazioni Srl
Advice Pharma Group srl

Not yet recruiting

Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7 (MIP7)

Prostate Cancer | Radiotherapy | Prostatectomy | 18F- Fluorocholine | PSMA PET | Tumor of Prostate
Spanish Oncology Genito-Urinary Group
Roche Farma, S.A; Dynamic Science S.L.

Active, not recruiting

Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer

Bladder Cancer

Spain
IRCCS San Raffaele
Advice Pharma Group srl

Completed

Ischemia in Patients With Non-obstructive Disease (INOCA) in Italy INOCA IT Multicenter Registry" (INOCAIT)

Cardiac Ischemia

Italy
Spanish Oncology Genito-Urinary Group
Astellas Pharma Inc; Apices Soluciones S.L.

Completed

Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer (PREMIERE)

Hormone-refractory Prostate Cancer

Spain
Spanish Breast Cancer Research Group
Roche Farma, S.A

Completed

Unraveling KAdcyla Resistance In Human Epidermal Growth Factor Receptor 2(HER2) Positive Advanced Breast Cancer (KATIA) (KATIA)

Advanced Breast Cancer

Spain
Spanish Breast Cancer Research Group
Roche Farma, S.A

Completed

Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal Cancer (BRECOL)

Metastatic Colorectal Cancer | Metastatic Breast Cancer

Spain
Spanish Breast Cancer Research Group
Roche Farma, S.A

Completed

Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis

Breast Cancer

Spain
TcLand Expression S.A.
Premier Research Group plc; Theradis pharma; Medpharmgene, Inc.

Terminated

Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy (PRINT)

Rheumatoid Arthritis

Canada, France, Hungary, Italy, Lithuania, Romania, Slovakia, Spain
Spanish Breast Cancer Research Group
Hoffmann-La Roche; Roche Farma, S.A

Terminated

A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast Cancer

Breast Cancer Invasive Nos

Spain
University Hospital, Brest
Roche Farma, S.A; Pierre Fabre Medicament; Groupe Francais De Pneumo-Cancerologie

Completed

Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer (VinMetAtezo)

Non-small Cell Lung Cancer

France

Clinical Trials Sponsored by Mesoestetic Pharma Group S.L.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations